BTRC and cancer: It has been suggested that the overexpression of β-TrCP1 induces β-catenin accumulation and the activation of the downstream targets of β-catenin such as cyclin D1, glutamine synthetase, and chemotaxin 2, leading to tumorigenesis in these cancers [89].